Chevy Chase Trust Holdings LLC Has $59.18 Million Stake in CVS Health Co. (NYSE:CVS)

Chevy Chase Trust Holdings LLC lifted its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 2.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 941,144 shares of the pharmacy operator's stock after buying an additional 18,734 shares during the quarter. Chevy Chase Trust Holdings LLC owned 0.07% of CVS Health worth $59,179,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. acquired a new position in CVS Health during the third quarter worth about $25,000. Livelsberger Financial Advisory purchased a new stake in CVS Health during the third quarter worth $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health in the third quarter valued at $32,000. First Community Trust NA increased its holdings in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock valued at $33,000 after acquiring an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $33,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Trading Up 0.7 %

CVS stock traded up $0.44 during mid-day trading on Tuesday, reaching $59.52. 3,863,489 shares of the stock traded hands, compared to its average volume of 11,283,307. The stock's fifty day moving average is $59.36 and its 200-day moving average is $58.77. The company has a market cap of $74.90 billion, a P/E ratio of 14.99, a P/E/G ratio of 1.02 and a beta of 0.54. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company's revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the business posted $2.21 EPS. As a group, sell-side analysts expect that CVS Health Co. will post 5.37 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.47%. CVS Health's payout ratio is 67.51%.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Royal Bank of Canada decreased their price objective on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research note on Friday, November 15th. Cantor Fitzgerald reissued a "neutral" rating and issued a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Barclays lowered their target price on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a research note on Thursday, November 7th. Evercore ISI increased their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a report on Tuesday, October 8th. Finally, TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a research report on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $70.50.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.